Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events

BACKGROUND: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, asso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Heart Fail
Main Authors: Wieselthaler, Georg M., Klein, Liviu, Cheung, Anson W., Danter, Matthew R., Strueber, Martin, Mahr, Claudius, Mokadam, Nahush A., Maltais, Simon, McGee, Edwin C.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059760/
https://ncbi.nlm.nih.gov/pubmed/33866829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados